Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Acta Cytologica|May 1, 1994
Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsyL Cavanna, G Civardi, F Fornari, et al.
Oncology|September 1, 1994
Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumorsM Di Stasi, G Sbolli, F Fornari, et al.
Leukemia|January 1, 1991
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trialM Federico, G Moretti, P G Gobbi, et al.
Cancer|March 15, 1997
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei LinfomiL Baldini, A Guffanti, P Gobbi, et al.
Cancer|June 15, 1992
Ultrasonically guided percutaneous splenic tissue core biopsy in patients with malignant lymphomasL Cavanna, G Civardi, F Fornari, et al.
The Journal of Reproductive Medicine|November 1, 1990
Vulvar intraepithelial neoplasia. A clinicopathologic study of 60 casesM Barbero, L Micheletti, M Preti, et al.
Leukemia & Lymphoma|April 1, 1995
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL)V Silingardi, M Federico, L Cavanna, et al.
European Journal of Haematology|July 1, 1996
In vivo biological response following low-dose interleukin-2 in complete remission B-cell non-Hodgkin's lymphoma patients. Italian Lymphoma Study Group (GISL)A Vecchi, L Cavanna, P Avanzini, et al.
Journal of Chemotherapy (Florence, Italy)|July 26, 2005
Oncologic emergencies secondary to advanced colorectal cancer successfully treated with oxaliplatin/5-fluorouracil/leucovorin: report of three casesL Cavanna, R Bertè, L Bidin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study GroupP G Gobbi, C Pieresca, M Federico, et al.
Pageof 10